Target intelligence / Profile preview

Peptidoglycan pentapeptide D-alanyl-D-alanine terminus (D-Ala-D-Ala)

Target
D-Ala-D-Ala
Molecular classification
Bacterial cell wall component, Peptidoglycan precursor, Other
01

Overview

The peptidoglycan pentapeptide D-alanyl-D-alanine (D-Ala-D-Ala) terminus is a fundamental structural element found in the cell wall precursors, specifically Lipid II, of Gram-positive bacteria (Nature Reviews Microbiology, 2008). Its primary biological function is to serve as a substrate for transpeptidase enzymes, also known as penicillin-binding proteins (PBPs), which facilitate the cross-linking of peptidoglycan layers (Journal of Biological Chemistry, 2011). This cross-linking is essential for maintaining the structural integrity and osmotic stability of the bacterial cell wall. In the context of infectious diseases, this terminus is the specific molecular target for the glycopeptide class of antibiotics, including vancomycin and teicoplanin (StatPearls, 2023). These drugs bind to the D-Ala-D-Ala motif through a highly specific network of five hydrogen bonds, effectively capping the precursor (PubMed, 2019). This binding sterically hinders the enzymes responsible for transglycosylation and transpeptidation, thereby halting cell wall synthesis and leading to bacterial cell death. Clinical challenges associated with this target include the emergence of resistance, where bacteria replace the terminal D-alanine with D-lactate or D-serine, drastically reducing drug affinity (Microbiology and Molecular Biology Reviews, 2005). Understanding this target is crucial for developing next-generation lipoglycopeptides designed to overcome such resistance mechanisms.

Other names
D-alanyl-D-alanineD-Ala-D-AlaPeptidoglycan precursor pentapeptideLipid II pentapeptide terminus
02

Mechanism of action

Glycopeptide antibiotics bind to the D-alanyl-D-alanine terminus of the peptidoglycan precursor via five hydrogen bonds, sterically inhibiting the transglycosylation and transpeptidation steps of cell wall synthesis (StatPearls, 2023).

03

Biological functions

Cell wall biosynthesisPeptidoglycan cross-linkingOsmotic stability
04

Disease associations

Bacterial infection
05

Safety considerations

NephrotoxicityOtotoxicityRed man syndrome (infusion reaction)Vancomycin-resistant Enterococci (VRE)Vancomycin-resistant Staphylococcus aureus (VRSA)
06

Interacting drugs

Vancomycin

4 more in the full profile.

07

Biomarkers

vanA genevanB genevanC geneMinimum Inhibitory Concentration (MIC)

Beyond the preview

Go deeper on Peptidoglycan pentapeptide D-alanyl-D-alanine terminus (D-Ala-D-Ala).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan pentapeptide D-alanyl-D-alanine terminus (D-Ala-D-Ala).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call